Indeed, IL-6 is strongly associated with the future risk of major cardiovascular events, including atherothrombosis9–11, and inhibition of the IL-6 signalling pathway may be beneficial for coronary artery disease, stroke, and arterial fibrillation12. Here, IL6 is linked to coronary artery disorder.